 Connection
Christopher Manuel to Mice, SCID
This is a "connection" page, showing publications Christopher Manuel has written about Mice, SCID.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.415 |
|
|
|
-
Pires EM, Pugazhenthi U, Fink MK, Habenicht LM, Fong DL, Leszczynski JK, Schurr MJ, Manuel CA. Antibiotic Treatment of Corynebacterium bovis-associated Clinical Disease in NSG Mice. Comp Med. 2023 Dec 01; 73(6):461-465.
Score: 0.203
-
Manuel CA, Pearson EC, Pugazhenthi U, Fink MK, Habenicht LM, Fong DL, Leszczynski JK, Schurr MJ. A Clinical Scoring Systems for the Evaluation of Corynebacterium bovis -associated Disease in NSG Mice. Comp Med. 2022 12 01; 72(6):386-393.
Score: 0.189
-
Kabos P, Finlay-Schultz J, Li C, Kline E, Finlayson C, Wisell J, Manuel CA, Edgerton SM, Harrell JC, Elias A, Sartorius CA. Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures. Breast Cancer Res Treat. 2012 Sep; 135(2):415-32.
Score: 0.023
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|